• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION MOMENTUM CRT-D; DEFIBRILLATOR, AUTOMATIC IMPLANTABLE CARDIOVERTER, WITH CRT-D

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION MOMENTUM CRT-D; DEFIBRILLATOR, AUTOMATIC IMPLANTABLE CARDIOVERTER, WITH CRT-D Back to Search Results
Model Number G126
Device Problems High impedance (1291); Incorrect, Inadequate or Imprecise Result or Readings (1535); Connection Problem (2900)
Patient Problem Electric Shock (2554)
Event Date 09/15/2023
Event Type  Injury  
Event Description
It was reported that a follow-up appointment, it was noted that the shock impedance measurement from the right ventricular (rv) lead was greater than 200 ohms in every position.The patient was hospitalized and a lead revision was attempted, but the subclavian vein was inaccessible so the physician aborted the procedure.The device data was forwarded to boston scientific technical services (ts) for review.Commanded shock testing was discussed to verify the shock impedance for a delivered shock.Additionally, the physician inquired the possibility of implanting a subcutaneous implantable cardiac defibrillator (s-icd) system in conjunction with the currently implanted cardiac resynchronization therapy defibrillator (crt-d) system.However, the patient did not pass the s-icd screening and ts stated that a s-icd system would not be recommended alongside the current need for left ventricular pacing.Diagnostic imaging was performed to verify the lead connections prior to commanded shock testing, but the physician was unable to conclusively determine an appropriate connection.Therefore, another surgical procedure was performed where the physician re-screwed the leads securely back into the header.However, when 1.1 joule and 41 joule shocks were delivered, a code 1005 appeared, indicating an open circuit condition.This information was forwarded to ts and a rv lead replacement procedure was strongly recommended to ensure effective shock delivery.At this time, the device and rv lead remain implanted and in-service.The patient is stable.
 
Event Description
It was reported that a follow-up appointment, it was noted that the shock impedance measurement from the right ventricular (rv) lead was greater than 200 ohms in every position.The patient was hospitalized and a lead revision was attempted, but the subclavian vein was inaccessible so the physician aborted the procedure.The device data was forwarded to boston scientific technical services (ts) for review.Commanded shock testing was discussed to verify the shock impedance for a delivered shock.Additionally, the physician inquired the possibility of implanting a subcutaneous implantable cardiac defibrillator (s-icd) system in conjunction with the currently implanted cardiac resynchronization therapy defibrillator (crt-d) system.However, the patient did not pass the s-icd screening and ts stated that a s-icd system would not be recommended alongside the current need for left ventricular pacing.Diagnostic imaging was performed to verify the lead connections prior to commanded shock testing, but the physician was unable to conclusively determine an appropriate connection.Therefore, another surgical procedure was performed where the physician re-screwed the leads securely back into the header.However, when 1.1 joule and 41 joule shocks were delivered, a code 1005 appeared, indicating an open circuit condition.This information was forwarded to ts and a rv lead replacement procedure was strongly recommended to ensure effective shock delivery.At this time, the device and rv lead remain implanted and in-service.The patient is stable.It was stated that due to clinical reasons, the physician elected not to perform surgical intervention and is continuing with close monitoring.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MOMENTUM CRT-D
Type of Device
DEFIBRILLATOR, AUTOMATIC IMPLANTABLE CARDIOVERTER, WITH CRT-D
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
4100 hamline avenue north
saint paul MN 55112
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
cashel road
clonmel
EI  
Manufacturer Contact
timothy degroot
4100 hamline avenue north
saint paul, MN 55112
6515826168
MDR Report Key17844750
MDR Text Key324605633
Report Number2124215-2023-53798
Device Sequence Number1
Product Code NIK
Combination Product (y/n)N
Reporter Country CodeIT
PMA/PMN Number
P010012/S436
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 02/13/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Expiration Date11/20/2021
Device Model NumberG126
Device Catalogue NumberG126
Device Lot Number104721
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 09/15/2023
Initial Date FDA Received09/29/2023
Supplement Dates Manufacturer Received02/05/2024
Supplement Dates FDA Received02/13/2024
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured12/20/2019
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age66 YR
-
-